In the midst of deep public angst over the rising cost of prescription meds, drug giant Pfizer agreed to pay roughly $785 million to put an end to a federal probe into whether it overcharged Medicaid programs for Protonix, a heartburn medication.

A new report suggests that hospitals in low-income areas may be unfairly hit by reimbursement models.

An Obama administration push to link Medicare reimbursements to performance got a big endorsement from major insurers Tuesday.

Is threat of punishment a better motivator for wellness than rewards?

Physicians who are subject to an intervention about the dangers of unnecessary antibiotic prescriptions changed what they do, a study shows.

PPACA insurers should receive $7.7 billion from the reinsurance program, the CMS announced.

Even with reductions in reimbursements for Medicare beneficiaries, the health program for senior citizens is a far more profitable endeavor for major insurance companies.

A recent survey by the Healthcare Trends Institute sheds light on employer attitudes towards the health insurance landscape, particularly wellness initiatives.